Envestnet Portfolio Solutions Inc. Cuts Stock Holdings in HCA Healthcare, Inc. $HCA

Envestnet Portfolio Solutions Inc. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 51.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,234 shares of the company’s stock after selling 5,507 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in HCA Healthcare were worth $2,443,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Sovran Advisors LLC boosted its holdings in shares of HCA Healthcare by 1.0% in the 3rd quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after buying an additional 22 shares during the last quarter. Centerpoint Advisors LLC boosted its holdings in shares of HCA Healthcare by 11.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after buying an additional 22 shares during the last quarter. Cary Street Partners Financial LLC boosted its holdings in shares of HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after buying an additional 22 shares during the last quarter. Plato Investment Management Ltd boosted its holdings in shares of HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares during the last quarter. Finally, Angeles Wealth Management LLC boosted its holdings in shares of HCA Healthcare by 2.4% in the 3rd quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock worth $432,000 after buying an additional 24 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 0.5%

Shares of HCA opened at $394.40 on Friday. The business’s 50-day moving average price is $465.16 and its 200-day moving average price is $483.61. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The stock has a market cap of $87.49 billion, a PE ratio of 13.56, a P/E/G ratio of 1.24 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the company earned $6.45 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on HCA shares. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. TD Cowen dropped their price objective on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, April 27th. KeyCorp dropped their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Stephens dropped their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Finally, UBS Group upped their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.